Skip to main content
Loading

Overcoming linker stability issues in antibody-drug conjugates

19 Feb 2025
Antibody Drug Conjugates
Overcoming linker stability issues in antibody-drug conjugates
  • Combatting deconjugation of linker-payloads through next-generation conjugation site chemistries.

  • Controlling promiscuity in enzyme-catalyzed linker-payload release.

  • Leveraging alternative payload release mechanisms to improve overall linker stability.

Industry Expert
Stephen Verespy, Scientific Leader - Abzena